A Retrospective Study of the Correlation Between Next-Generation Sequencing and Immunohistochemical Detection of TP53 in Colorectal Cancer
Technology in Cancer Research & Treatment · 2026
DOI: 10.1177/15330338261420099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2026. Verfasst von Jingjing Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Suppressor Protein p53, High-Throughput Nucleotide Sequencing, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Fujian Provincial Health and Construction Commission, Young and middle-aged backbone personnel Training Project.
Abstract (Originalsprache)
Introduction
This retrospective study aimed to investigate the correlation between TP53 identified via next-generation sequencing (NGS) and p53 expression in colorectal adenocarcinoma (CRC), as assessed by immunohistochemistry (IHC). Additionally, we characterized p53 IHC staining patterns and sought to determine the optimal threshold for p53 expression as a surrogate for TP53 mutation status.
Methods
In this retrospective cohort analysis, we included 294 archived surgically resected CRC specimens from patients who did not receive preoperative chemotherapy were analyzed. All data were collected from pathology database and electronic medical records. TP53 mutations were identified using NGS, and p53 expression was evaluated by IHC. The correlation between mutation status and IHC staining patterns was assessed, and sensitivity and specificity were calculated.
Results
The TP53 mutation rate was 78.2%, comprising missense (68.4%), nonsense (12.4%), frameshift (11.0%), and splice-site (8.3%) mutations. Missense mutations were associated with nuclear p53 staining, while frameshift mutations mostly showed loss of expression. Nonsense and splice-site mutations exhibited diverse patterns, including loss of expression, nuclear staining with/without cytoplasmic staining, or cytoplasmic staining alone. Among cases with loss of p53 expression, the TP53 mutation rate was 88.9%. When the proportion of strong p53-positive cells exceeded 55%, the missense mutation-positivity rate increased significantly (P < 0.05). The sensitivity and specificity of p53 IHC in predicting TP53 mutations were 92.3% and 94.8%, respectively.
Conclusions
CRC predominantly exhibited missense TP53 mutations. p53 IHC revealed diverse expression patterns, including overexpression, complete loss, cytoplasmic staining, and normal-type patterns. Strong p53 expression (>55%) correlated closely with TP53 missense mutations, supporting IHC as a reliable surrogate. However, cases showing loss of p53 expression should undergo gene sequencing to confirm mutation status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- Department of Pathology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- Department of Pathology, Fuzhou Second General Hospital, Fuzhou, China.
ORCID-Profile: Jingjing Wu
Förderung
- National Natural Science Foundation of China
- Fujian Provincial Health and Construction Commission, Young and middle-aged backbone personnel Training Project
Zitieren
APA
Wu, J., Yu, H., Huang, S., & Chen, X. (2026). A Retrospective Study of the Correlation Between Next-Generation Sequencing and Immunohistochemical Detection of TP53 in Colorectal Cancer. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338261420099
Vancouver
Wu J, Yu H, Huang S, Chen X. A Retrospective Study of the Correlation Between Next-Generation Sequencing and Immunohistochemical Detection of TP53 in Colorectal Cancer. Technology in Cancer Research & Treatment. 2026. doi:10.1177/15330338261420099
BibTeX
@article{Wu2026,
author = {Wu, Jingjing and Yu, Haifeng and Huang, Shanshan and Chen, Xiangna},
title = {A Retrospective Study of the Correlation Between Next-Generation Sequencing and Immunohistochemical Detection of TP53 in Colorectal Cancer},
journal = {Technology in Cancer Research & Treatment},
year = {2026},
doi = {10.1177/15330338261420099}
}
EUVIMED